Gilead Sciences Inc.

GILD | NASDAQ

Price Alert Chart Builder DCF Calculator

$150.56

+$0.45 (+0.30%)

At close: Sep 21, 2026, 4:00 PM ET

$149

-$1.56 (-1.04%)

After-hours: Sep 21, 2026, 7:57 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	29.44B	28.75B	27.12B	27.28B	27.31B	24.69B
Cost of Revenue	6.23B	6.25B	6.5B	5.66B	6.6B	4.57B
Gross Profit	23.21B	22.5B	20.62B	21.62B	20.7B	20.12B
Operating Income	11.7B	1.66B	7.61B	7.33B	9.92B	4.07B
Interest Income	349M	281M	376M	106M	n/a	n/a
Pretax Income	9.8B	690M	6.86B	5.81B	8.28B	1.67B
Net Income	8.51B	480M	5.67B	4.59B	6.23B	123M
Selling & General & Admin	5.71B	6.09B	6.09B	5.67B	5.25B	5.11B
Research & Development	5.8B	5.91B	5.72B	4.98B	4.6B	5.04B
Other Expenses	n/a	8.84B	1.21B	3.64B	939M	5.9B
Operating Expenses	11.51B	20.84B	13.01B	14.29B	10.79B	16.05B
Interest Expense	1.02B	977M	944M	935M	1B	984M
Selling & Marketing Expenses	3.52B	3.45B	3.27B	778M	735M	795M
Cost & Expenses	17.74B	27.09B	19.51B	19.95B	17.39B	20.62B
Income Tax Expense	1.29B	211M	1.25B	1.25B	2.08B	1.58B
Shares Outstanding (Basic)	1.24B	1.25B	1.25B	1.26B	1.26B	1.26B
Shares Outstanding (Diluted)	1.26B	1.26B	1.26B	1.26B	1.26B	1.26B
EPS (Basic)	6.84	0.38	4.54	3.66	4.96	0.10
EPS (Diluted)	6.78	0.38	4.50	3.64	4.93	0.10
EBITDA	13.58B	4.43B	10.5B	8.85B	11.33B	4.13B
EBIT	10.82B	1.67B	7.8B	6.75B	9.28B	2.65B
Depreciation & Amortization	2.76B	2.77B	2.69B	2.1B	2.05B	1.48B